n,n-dimethylarginine has been researched along with HIV Coinfection in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 13 (92.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berge, RK; Gaardbo, JC; Gerstoft, J; Hove-Skovsgaard, M; Kolte, L; Nielsen, SD; Seljeflot, I; Svardal, A; Trøseid, M; Ullum, H; Winding, K | 1 |
| Alam, K; Dirajlal-Fargo, S; El Kamari, V; Funderburg, N; Labbato, D; Longenecker, CT; McComsey, GA; Pirro, L; Sattar, A; Wilson, WH | 1 |
| Aukrust, P; Gaardbo, JC; Gelpi, M; Gerstoft, J; Hoel, H; Holm, K; Hov, JR; Hove-Skovsgaard, M; Kummen, M; Nielsen, SD; Nwosu, F; Rudi, K; Seljeflot, I; Trøseid, M; Ueland, PM; Ullum, H; Valeur, J | 1 |
| Deeks, SG; Ganz, P; Grunfeld, C; Hsue, PY; Leone, A; Martin, JN; Nitta, EM; Parikh, RV; Scherzer, R | 1 |
| Hudson, CL; Ipp, H; Zemlin, AE | 1 |
| Deeks, SG; Ganz, P; Hsue, PY; Hur, S; Leone, A; Macgregor, JS; Martin, JN; Mistry, V; Nitta, EM; Parikh, RV; Scherzer, R | 1 |
| Beltrán, LM; Blanco-Colio, LM; de Pablo Bernal, RS; Egido, J; Ferrando-Martinez, S; García Morillo, JS; Genebat, M; Moreno, JA; Moreno-Luna, R; Muñoz Hernández, R; Noval, ML; Villar, JR | 1 |
| Gerstoft, J; Kvale, D; Manner, IW; Nielsen, SD; Os, I; Pedersen, KK; Seljeflot, I; Trøseid, M | 1 |
| Gerstoft, J; Haissman, JM; Hasbak, P; Haugaard, AK; Kjær, A; Knudsen, A; Kristoffersen, US; Lebech, AM; Nielsen, SD; Ostrowski, SR; Pedersen, KK; Seljeflot, I; Trøseid, M | 1 |
| Knysz, B; Małyszczak, K; Szymanek-Pasternak, A; Szymczak, A; Zalewska, M | 1 |
| Fuchs, D; Gostner, JM; Kurz, K | 1 |
| Fuchs, D; Kurz, K; Sarcletti, M; Teerlink, T; Weiss, G; Zangerle, R | 1 |
| Berkheimer, SB; Jang, JJ; Krishnaswami, A; Merchant, M | 1 |
| Badley, AD; Baker, JV; Bernardino, JI; Duprez, D; Freiberg, M; Lundgren, JD; Neaton, JD; Neuhaus, J; Nixon, DE; Tracy, RP | 1 |
1 trial(s) available for n,n-dimethylarginine and HIV Coinfection
| Article | Year |
|---|---|
Effect of statin on arginine metabolites in treated HIV-infection.
Topics: Adult; Anti-HIV Agents; Arginine; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Chi-Square Distribution; Cholesterol, LDL; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Linear Models; Male; Middle Aged; Ohio; Risk Factors; RNA, Viral; Rosuvastatin Calcium; Time Factors; Treatment Outcome; Viral Load | 2017 |
13 other study(ies) available for n,n-dimethylarginine and HIV Coinfection
| Article | Year |
|---|---|
HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; HIV Infections; Humans; Inflammation; Male; Methylamines; Middle Aged; Risk Factors; Tandem Mass Spectrometry | 2017 |
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction.
Topics: Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Endothelium; Feces; Female; Gastrointestinal Microbiome; HIV Infections; Humans; Inflammation; Kynurenine; Male; Metabolism; Middle Aged; Neopterin; Risk Factors; RNA, Ribosomal, 16S; Tryptophan | 2018 |
Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals.
Topics: Adult; Arginine; Biomarkers; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Endothelium, Vascular; Female; HIV Infections; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Nitric Oxide; Predictive Value of Tests; Risk Factors; Viral Load | 2013 |
The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression.
Topics: Adenosine Deaminase; Adult; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cross-Sectional Studies; Female; HIV Infections; HIV Seropositivity; Humans; Immunoglobulin G; Interleukin-6; Male; Viral Load | 2014 |
Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.
Topics: Adult; Arginine; Biomarkers; Blood Pressure; Catheterization, Swan-Ganz; Cohort Studies; Echocardiography; Familial Primary Pulmonary Hypertension; Female; HIV Infections; Humans; Hypertension, Pulmonary; Male; Middle Aged; Prospective Studies | 2014 |
Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.
Topics: Adult; Anti-Retroviral Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Arginine; C-Reactive Protein; Case-Control Studies; Coinfection; Cytokine TWEAK; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interleukin-6; Male; Middle Aged; Receptors, Cell Surface; Tumor Necrosis Factors; Vascular Cell Adhesion Molecule-1; Young Adult | 2014 |
Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Arginine; Bacterial Translocation; Biomarkers; Cardiovascular Diseases; Female; Fibrin Fibrinogen Degradation Products; HIV Infections; Humans; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Middle Aged; Monocytes | 2014 |
Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis.
Topics: Adult; Arginine; Atherosclerosis; Biomarkers; Cross-Sectional Studies; Endothelial Cells; Female; HIV Infections; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Plasma | 2016 |
Risk factors for chronic kidney disease do not influence the serum levels of asymmetric dimethylarginine in HIV-1-infected patients without significant renal disease.
Topics: Adult; Aged; Anti-HIV Agents; Arginine; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Risk Factors; Young Adult | 2016 |
Asymmetric dimethylarginine: a risk indicator or pathogenic factor?
Topics: Arginine; HIV Infections; HIV-1; Humans; Renal Insufficiency, Chronic | 2016 |
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Risk Factors; Th1 Cells; Young Adult | 2009 |
Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus.
Topics: Adult; Arginine; Biomarkers; Calcinosis; California; Case-Control Studies; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; RNA, Viral; Tomography, X-Ray Computed; Up-Regulation | 2011 |
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Arginine; Biomarkers; CD40 Antigens; Female; HIV Infections; Humans; Inflammation; Male; Middle Aged; P-Selectin; Plasma; Randomized Controlled Trials as Topic; Virus Replication | 2012 |